Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070498 · ClinicalTrials.gov registry record · Phase 1
Trichuris Suis Ova in Peanut and Tree Nut Allergy
A Phase 1 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01070498 is a Phase 1 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT01070498, a Phase 1 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether Trichuris suis ova, a potential immunomodulator, is safe in adults and children allergic to peanut or tree nuts.
Interventions
- DRUG Trichuris suis ova (TSO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01070498
The ClinicalTrials.gov registry entry for NCT01070498 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trichuris suis ova (TSO) is the first listed.
NCT01070498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01070498 about?
NCT01070498 is a clinical study titled "Trichuris Suis Ova in Peanut and Tree Nut Allergy". The goal of this study is to determine whether Trichuris suis ova, a potential immunomodulator, is safe in adults and children allergic to peanut or tree nuts.
What is the current status of trial NCT01070498?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2010-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01070498?
The interventions under investigation include: Trichuris suis ova (TSO) (DRUG).
Who is sponsoring clinical trial NCT01070498?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.